Nanomedicine News

RSS

New Inhalable Dry Powder Treatment for Lung Cancer Increases Survival Rates

A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This researc...

16 Nov 2010

Suzhou Natong Bionanotechnology Receives Silver Award for Innovative Drug Delivery Device

Suzhou Natong with its US partner Nanomed Devices, Inc. announced yesterday that they won the Silver Prize of the Asian Innovation Awards 2010 at the Biobay Investor Forum. The award was sponsored by The Wall Street J...

16 Nov 2010

European Health Technology Clusters Launch Health Axis Europe at Regional Development Summit

Representatives of the European health technology clusters in Leuven (Belgium) and the Rhine-Neckar Metropolitan Region (Biotech Cluster Rhine-Neckar BioRN, Germany) now announced at the Regional Development Summit in Heidelberg the launch of a new initiative called “Health Axis Europe”.

16 Nov 2010

UC NanoEngineers to Develop Biodegradable Frames for Heart Tissues

University of California, San Diego NanoEngineers won a grant from the National Institutes of Health (NIH) to develop the tools to manufacture biodegradable frames around which heart tissues – functional blood vessels included – will grow. Developing methods for growing tissues that mimic nature's fine-grained details, including vasculature, could lead to breakthroughs in efforts to grow replacement cardiac tissues for people who have suffered a heart attack. The work could also lead to better systems for growing and studying cells, including stem cells, in the laboratory.

16 Nov 2010

Gadonanotubes Are More Effective in Tracking Stems Cells in Body

Gadonanotubes (GNTs) developed at Rice University are beginning to show positive results in a study funded by a federal stimulus grant through the National Institutes of Health (NIH) last year.

15 Nov 2010

Cerulean to Present on Nanopharmaceutical Platform at Two Major European Conferences

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that the Company’s senior executives will be presenting at two major European conferences to be held in Munich and Berlin, Germany.

From Cerulean Pharma 15 Nov 2010

NaturalNano's Halloysite Nanotubes Improve Separation of CTCs from Blood

NaturalNano, Inc. (Pink Sheets:NNAN) (Frankfurt:N3N) announced that Andrew Hughes is presenting today research from Cornell University's Department of Biomedical Engineering that reports significant improvement in th...

15 Nov 2010

Nanotechnology Corporation Finances Production of Transdermal Drug Delivery Systems and Nanostructured Biopolymer Medical Implants

The Russian Corporation of Nanotechnologies, established in 2007 to enable Government policy in the field of Nanotechnology, will finance production of transdermal drug delivery systems and nanostructured biopolymer medi...

14 Nov 2010

Findings Could Help in Developing Treatment for Pulmonary Disease using Nanotechnology

Using a real-time imaging system, scientists have tracked a group of near-infrared fluorescent nanoparticles from the airspaces of the lungs into the body and out again, providing a description of the characteristics and behavior of the particles that could be used in developing therapeutic agents to treat pulmonary disease.

13 Nov 2010

IRB Scientists Present World's Largest Data Base on Protein Motions

After four years of conducting intensive calculations in the supercomputer MareNostrum at the Barcelona Supercomputing Center, scientists headed by Modesto Orozco at the Institute for Research in Biomedicine (IRB Barcelo...

12 Nov 2010